Denpidazone
- Level
- Commodity
- Parent
- 51152000
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51152026This classification denotes a muscle relaxant with the molecular formula C20H20N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier E7N3FX2T1J, chemically known as 3,6-pyridazinedione, 1,2-dihydro-4-butyl-5-hydroxy-1,2-diphenyl- but generally known as denpidazone, which bears US NIH Compound Identifier 206004. European Medicines Agency schedules Denpidazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06979MIG. The term DENPIDAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). DENPIDAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule denpidazone under HS 29339990 and SITC 51577. As of Q4 2014, DENPIDAZONE remains the US FDA Preferred Term for this commodity. Denpidazone bears US NLM identifiers UMLS ID C2699589 and NCI Concept Code C77599. SMILES: OC1N(N(C(=O)C(=O)C1CCCC)C1CCCCC1)C1CCCCC1.
Same parent
Under 51152000 · 74Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.